Federated Hermes’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Federated Hermes’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-6,954	Closed	-$156K	–	2144
2015 Q2	$156K	Buy	+6,954	New	+$171K	﹤0.01%	1536
2015 Q1	–	Sell	-2,000	Closed	-$44K	–	2146
2014 Q4	$44K	Sell	2,000 -16	-0.8%	-$328	﹤0.01%	1679
2014 Q3	$38K	Sell	2,016 -3,702	-65%	-$74.4K	﹤0.01%	1675
2014 Q2	$133K	Sell	5,718 -19,168	-77%	-$473K	﹤0.01%	1546
2014 Q1	$837K	Buy	24,886 +21,909	+736%	+$738K	﹤0.01%	1223
2013 Q4	$88K	Buy	+2,977	New	+$54.5K	﹤0.01%	1601

Other funds holding OMED

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Apex Capital Orinda, California $938M AUM 4.67% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Federated Hermes's OMED Position: Q3 2015 in Review

Federated Hermes sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2015, closing a stake of 6,954 shares — an estimated $156K sold.

Federated Hermes first reported a position in OMED in Q4 2013 and held it in 6 quarters. The position peaked at $837K in Q1 2014. 87 funds tracked by Wall St. Rank hold OMED as of Q3 2015.

Federated Hermes reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
Federated Hermes sold 6,954 OncoMed Pharmaceuticals, Inc. shares in Q3 2015, an estimated $156K.
Federated Hermes first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 6 quarters.
Federated Hermes's OncoMed Pharmaceuticals, Inc. position peaked at $837K in Q1 2014.
87 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2015.

Based on Federated Hermes's 13F filing for Q3 2015, filed 13 Nov 2015.